Loading clinical trials...

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures | Clinical Trials | Clareo Health

RECRUITING

BioBrace® Augmentation in Anterior Cruciate Ligament Reconstruction Procedures

Real World Evaluation of the Safety and Effectiveness of BioBrace® Augmentation in Anterior Cruciate Ligament (ACL) Reconstruction Procedures

NCT06948591•CONMED Corporation

View on ClinicalTrials.gov

Summary

This research study will evaluate mid-term clinical safety and performance outcomes of the BioBrace® Reinforced Implant when used to augment a tissue graft during anterior cruciate ligament (ACL) reconstruction.

Detailed Description

This is a multi-center, single arm, open label registry investigating anterior cruciate ligament reconstruction (ACLR) procedures where the tissue graft is augmented with BioBrace®. Subjects meeting the inclusion/exclusion criteria will be enrolled retrospectively or prospectively. Clinical evaluations will be conducted at baseline (pre-operatively) and at 6 months, 1-, 2-, and 3-years post-operatively using various patient-reported outcome measures to assess pain, function, return to activity, and safety post-surgery.

Eligibility

Age

14 - 70 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•1. Underwent ACL reconstruction with a tissue graft augmented with BioBrace® within the past 24 months from study start date or scheduled to undergo ACL reconstruction with a tissue graft augmented with BioBrace®.
•2. Between 14 and 70 years old at the time of surgery.
•3. Can understand the content of the subject information / Informed Consent Form (ICF) for the prospective portion of the study.
•4. Is willing and able to participate in the prospective data collection protocol and comply with the required data collection.
•5. If the subject has already undergone ACLR within the past 24 months, subject must have at least two (2) of the following measures at baseline and 1 year post-operatively:
•1. International Knee Documentation Committee (IKDC)
•2. Knee Injury and Osteoarthritis Outcome Score Junior (KOOS, JR.)
•3. Patient-Reported Outcomes Measurement Information System (PROMIS-10)
•4. Tegner Activity Scale (TAS)
•5. Anterior Cruciate Ligament - Return to Sport After Injury (ACL-RSI)
+1 more criteria

Exclusion Criteria

•1. Has other concurrent medical or other conditions (chronic or acute in nature) that in the opinion of the participating investigator may prevent participation or otherwise render subject ineligible for the study.
•2. Is currently participating in an investigational therapy (device and/or pharmaceutical) within 30 days prior to entering the study or such treatment is planned during the 3 years following enrollment into the study.
•3. Underwent or scheduled to undergo a multi-ligament reconstruction procedure (excluding cases where a torn MCL is treated non-operatively).
•4. Females of child-bearing potential who are either pregnant or breastfeeding at the time of surgery.

Locations (1)

ConMed

New Haven, Connecticut, United States

Key Dates

Start Date

April 8, 2025

Primary Completion Date

June 1, 2030

Completion Date

June 1, 2030

Last Updated

November 26, 2025

Enrollment

500

ESTIMATED participants

Conditions

ACL Tears

Interventions

Anterior cruciate ligament reconstruction with BioBrace® augmentation

DEVICE

Arthroscopic anterior cruciate ligament reconstruction

PROCEDURE

Contacts

Evona Wojtanowski

CONTACT

ClinicalAffairs@conmed.com